BPA Call HT001415A0024-0008
Award Date
6/24/16
Potential Completion Date
9/30/16
Potential Value
$400K
Federal Agency
Defense Health Agency
Awardee
The Compounding Center Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The $300,000 contract provides the DHA with a variety of pharmaceutical products, including blood products, oncology drugs, and other injectable, oral, and inhalation medications to address shortages impacting patient care at military and civilian treatment facilities. The contract is structured as a Blanket Purchase...
This federal contract award was issued by the Defense Health Agency, a component of the Department of Defense, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The $400,000 firm fixed price contract is for the delivery of various shortage pharmaceuticals to support patient care at military hospitals and clinics. The contract has no set-aside designation. The Compounding Center Inc. has received over $700,000 in previous contract awards from the...
This is a firm fixed price contract awarded by the Defense Health Agency, a component of the Department of Defense, to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide specialized pharmaceutical compounds and medications to address shortages impacting patient care at military and civilian treatment facilities. The $650,000 contract is a blanket purchase agreement (BPA) call that allows for the expedited acquisition of customized drugs and...
The Defense Health Agency awarded a firm fixed price blanket purchase agreement (BPA) call to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business, to provide prescription pharmaceuticals such as vinblastine, carimune, and oncological medications. The $250,000 contract has no set-aside designation and supports the urgent needs of military treatment facilities, including Walter Reed National Military Medical Center, by delivering specialized, customized...
This contract award is for the delivery of various shortage pharmaceuticals to the Defense Health Agency, an agency within the Department of Defense. The prime contractor, The Compounding Center Inc., is a minority-owned, small disadvantaged business that provides specialized pharmaceutical compounds and medical supplies to government agencies. The contract is a blanket purchase agreement with a ceiling value of $300,000.00, allowing for the expedited acquisition of customized medications and...
This is a Firm Fixed Price contract awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to TDS Med, Inc., a small disadvantaged business, to provide pharmaceutical products. The contract has a ceiling value of $300,000.00 and runs from October 1, 2014 to September 30, 2015. It is a call order under a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency in September 2019 to provide pharmaceutical products and supplies, including shortage...
The U.S. Defense Health Agency (DHA) awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to TDS Med, Inc., a self-certified small disadvantaged business, to provide shortage pharmaceuticals for the Walter Reed National Military Medical Center (WRNMMC). The contract, valued at $300,000.00, has an ultimate completion date of September 30, 2016. This award is under a larger $2 million BPA with TDS Med, Inc. that was originally awarded by DHA in September 2019 to provide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $33,257.40 contract provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical centers. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price Blanket Purchase Agreement (BPA) contract awarded by the Defense Health Agency (DHA) to Health Care Logistics Inc. (HCL), a for-profit, veteran-owned small business. The $200,000 contract is for the provision of various pharmaceutical supplies to support the DHA's mission of maintaining military health system readiness and beneficiary care. The contract has a period of performance through September 30, 2016 and was awarded on January 14, 2016. HCL currently holds two...
This federal contract award was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency's (DLA) Medical Supply Chain division. The $118,406.60 firm fixed-price delivery order is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products are to support the recurring medical supply needs of military...